New Colombia Resources Inc fka NEWC

[quipu]

And Cannabis is excellently positioned!!

"...
New Colombia's subsidiary, Sannabis SAS, continues legally producing medical marijuana products on an autonomous Indian Nation in Norte del Cauca, Colombia. Sannabis has reached breakeven in the month of September; high profit margins provide steady cash flow that is reinvested in the company to continue growing operations. In addition to their own crops, Sannabis has over 1500 plants are in production with 15 indigenous families; they set up the families with 100 plants then buy their medical marijuana to produce high quality medicines distributed throughout Colombia. Sannabis is working with Governors of neighboring tribes to set up several hundred families with 100 plants each.
Sannabis sets up workshops to train growers in the care and organic nurturing of cannabis plants using GMP standards. Most of these growers are indigenous single mothers directly affected by Colombia's conflict that are seeking a legal sustainable livelihood and enthusiastically apply organic and good manufacturing practices. Sannabis quality control personnel closely monitor this process. Sannabis and its sister foundation, Taller Libre, formed a collaboration agreement with a major university to establish a graduate programs on hemp cultivation and processing.
Sannabis was featured in the October edition of Naturalissimo Magazine, a publication serving over 3000 stores selling Natural products. Sannabis products use the following plants, marijuana, coca, calendula, higuerilla, nettle, and rosemary. Sannabis is working with this organization to establish distributorships in these stores.
..."

http://www.marketwired.com/press-release/mining-medical-cannabis-company-develops-new-industry-post-conflict-colombia-otc-pink-newc-2065758.htm

"...
New Colombia Resources Inc. Is at the Forefront of This New Agro-Industry.
...
New Colombia Resource's subsidiary, Sannabis SAS, has been legally producing medicines on the TOEZ Indian reservation for two years. This site in Norte del Cauca has ideal growing conditions and is home to some of the most sought after strains in the World. Sannabis is securing their market share for medical marijuana products by working directly with indigenous families, insuring their ability to organically produce clones of Sannabis strains, and guaranteeing the purchase of their crop every quarter. Sannabis then manufactures and packages the products on the reservation. A state of the art laboratory built to INVIMA standards is nearing completion. This lab will process hundreds of pounds of medical cannabis per day. Sannabis currently operates at gross profit margins between 250% to over 2000% on their products. These profits are reinvested in securing high quality standards for their medicines and new distribution channels.
"We have been promoting and investing in Colombia's legal medical marijuana products market for some time and believe we will grow significantly once our state of the art laboratory is completed next month. Colombia's administration should be recognized on their forward thinking and courage to right a wrong that has plagued this country for too long," said John Campo, President of New Colombia Resources. "We aim to make 'Made in Colombia' medical marijuana and hemp products the gold standard," further stated Mr. Campo.
In addition to medical marijuana products, New Colombia intends to plant hundreds of hectares of industrial hemp to cost effectively produce bio-diesel with extractors near production zones. ..."

http://www.marketwired.com/press-release/colombia-health-minister-announces-decree-legalize-commercialization-medical-marijuana-otc-pink-newc-2068433.htm


"New Colombia Resources to Apply for an Orphan Drug Designation With the FDA for a Medical Marijuana Pharmaceutical Drug to Treat a Rare Pediatric Disease
Company Subsidiary, Sannabis, Begins Medical Marijuana and Hemp Workshop at Colombia University
SUNNY ISLES BEACH, FL and CALI, COLOMBIA--(Marketwired - Nov 10, 2015) - New Colombia Resources, Inc.(OTC PINK: NEWC) ("New Colombia" or the "Company"), a U.S. company with specialty metallurgical coal, medical marijuana, and hemp assets, is pleased to announce they are partnering with Advanced Imaging Projects (AiP) on the development, clinical trials, and accelerated regulatory agency approvals of a cannabinoid for multiple medical indications with a focus on treatment of a rare pediatric disease. The company and its partner are studying several indications to apply for. Once the application is submitted the designation is expected within a few months. Cannabinoid pharmaceuticals are expected to be a multi-billion dollar industry.
Advanced Imaging Projects (AiP) is a clinical stage specialty biopharmaceutical company based in South Florida that develops molecular medicines for diagnosis and treatment of oncological, neurological, and infectious diseases. They are committed to providing drugs that can enhance patient outcomes and improve quality-of-life. "AiP received several million dollars in peer reviewed competitive research grants and similarly, could anticipate support for this project from the U.S. National Institute of Health, which may also be a potential collaborator," stated Dr. Stanley Satz, PhD., Chairman and Chief Scientific Officer of Advanced Imaging Partners. "There would be great personal satisfaction in this project as I lived in Colombia for 5 years while working for the World Health Organization there," further commented Dr. Satz.
Various orphan drug designations were applied for and received by AiP from the U.S. Food and Drug Administration (FDA) for tuberculosis, pediatric neuroblastoma, Moyamoya disease and multiple system atrophy, a Parkinsonian movement disorder. These designations confer significant advantages including waiver of application filing fees, expedited approval, government grants, and reduced number of patients in clinical trials. Dr. Satz stated, "My sense is that by working together with New Colombia Resources, similarly we could obtain this for the cannabinoid under development."
Last year only three orphan drug designations were approved for rare pediatric disease, AiP received one of them. Visit http://www.orphan-drugs.org/2014/11/04/fda-orphan-drug-designations-october-2014/. Last week AiP received an approval for another orphan drug designation as well.
Dr. Satz has developed and obtained U.S. Food and Drug Administration approval for Strontium Chloride Sr89, an injectable therapeutic radiopharmaceutical for treatment of prostate and breast cancer metastatic bone pain (See Strontium or Bio-Nucleonics in the FDA Orange Book). The drug is also approved by INVIMA, Colombia's equivalent of the FDA. "After meeting with Stan, I'm convinced he is the right partner for our FDA application, doing the clinical trials in Colombia in collaboration with Universities and Government agencies will greatly reduce the costs of clinical trials," stated John Campo, Chairman and President of New Colombia Resources.
New Colombia Resources and AiP are building a team of physicians, biostatisticians, and toxicologists in preparedness of FDA trials and a pre- IND meeting.
Additionally, Sannabis began their first workshop at a major university in Colombia to set up protocols for accredited courses in Agronomic and Agro Industrial Engineering for hemp production and medical marijuana studies. Students and faculty are very interested in exploring this new industry. The next workshop will be December 4th. The first hemp crops are scheduled to be planted in January at the University. More specific details will follow in the coming weeks.
..."
http://www.marketwired.com/press-release/new-colombia-resources-apply-orphan-drug-designation-with-fda-medical-marijuana-pharmaceutical-otc-pink-newc-2072088.htm

"New Colombia Resources Inc. (NEWC) Announces Approval of Medical Marijuana in Colombia

Sannabis met with Government Officials last week

SUNNY ISLES BEACH, Fla. & CALI, Colombia--(BUSINESS WIRE)-- New Colombia Resources, Inc. (OTC PINK: NEWC) ("New Colombia" or the "Company"), a U.S. company with specialty metallurgical coal, medical marijuana, and hemp assets, reports that a decree was announced by Colombia’s Minister of Health regulating the use of medical marijuana. The decree was signed by the Minister of Health, Minister of Agriculture, and Minister of Justice. The President of Colombia, Juan Manuel Santos, is expected to sign it later on today.

New Colombia Resources’ subsidiary, Sannabis, was invited last week to the Ministry of Justice to inform them of the decree coming out today. Sannabis is proud to become the pilot for this new industry; they have been using the techniques and protocols established in the articles of the decree and enjoy support from regulatory agencies.

“We were the first ones to introduce the concept of legalizing medical marijuana in Colombia, and with thousands of plants in production and hundreds of patients, we couldn’t be happier with today’s developments. Our phones are ringing off the hook as we get ready for the next chapter of making Sannabis the best brand of medical marijuana products on the market,” stated John Campo, President of New Colombia Resources Inc.

Company subsidiary, Sannabis SAS, has been cultivating medical marijuana and producing high quality products for over 2 years in Colombia. They supply foundations for children with Epilepsy and sponsor activities for their benefit. They aim to become the leaders of medical marijuana products in Colombia.
..."

http://www.businesswire.com/news/home/20151112006160/en/Colombia-Resources-NEWC-Announces-Approval-Medical-Marijuana

Yes!!